Main Management ETF Advisors, LLC Ligand Pharmaceuticals Inc Put Options Transaction History
Main Management ETF Advisors, LLC
- $2.06 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding LGND
# of Institutions
280Shares Held
19MCall Options Held
9.5KPut Options Held
8.1K-
Black Rock Inc. New York, NY2.87MShares$293 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.06MShares$210 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.03MShares$105 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3906KShares$92.6 Million0.12% of portfolio
-
Dimensional Fund Advisors LP Austin, TX745KShares$76.1 Million0.02% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $1.73B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...